查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
COVID-19 影响分析的仿製药市场，按类型、按给药途径、按产品、按应用、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1339904

COVID-19 影响分析的仿製药市场，按类型、按给药途径、按产品、按应用、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Generic Pharmaceuticals Market with COVID-19 Impact Analysis, By Type, By Route of Administration, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 374 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年仿製药市场规模为 3617.010 亿美元，2023 年至 2030 年復合年增长率为 8.31%。

仿製药市场-市场动态：

  • 慢性病发病率增加。
  • 慢性病发病率的上升是仿製药市场的主要驱动力之一。随着越来越多的人被诊断为慢性病，他们会寻求其他药物来治疗。品牌药物的成本较高，而仿製药的成本较低，并且与品牌药物的化学成分相同。由于仿製药的成本较低、化学成分的一致性和效力较高，患者选择仿製药而非品牌药。由于慢性病治疗时间的延长，仿製药的销量也随之增加。例如，世界卫生组织 (WHO) 预测未来 10 年慢性病相关死亡人数将增加 17%。

仿製药市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球仿製药市场在预测期内（2023-2030 年）每年将以 8.31% 左右的复合年增长率增长
  • 根据类型细分，预计简单仿製药产品将在 2022 年占据最大市场份额
  • 从应用来看，2022年心血管是主导类型
  • 从产品细分看，2022年小分子为主导类型
  • 按给药途径细分，2022年口服为主导类型
  • 按地区划分，北美是 2022 年的主要收入来源

仿製药市场-細項分析：

  • 全球仿製药市场根据类型、给药途径、产品、应用和地区进行细分。
  • 市场根据类型分为几类：简单仿製药、特殊仿製药和生物仿製药。简单仿製药领域主导着市场。简单的仿製药需要进行生物等效性研究，并有明确的开发计划和监管方法。这些产品的化学成分与参考产品相同，市场上已经充斥着简单的仿製药产品。儘管如此，由于政府试图削减药品医疗保健支出并增加新的批准和上市，预计市场将扩大。
  • 市场根据给药途径分为几类：口服、注射、吸入和其他。口腔细分市场占据主导地位。口服剂量的许多好处，包括其简单性和无需护理需求，提高了患者的接受度和依从性。为了治疗 COVID-19 患者，Zenera Pharma 于 2022 年 9 月推出了 Paxlovid 的仿製药。每盒这些口服药物包含 20 粒 Nirmatrelvir 药丸，售价为 63.74 美元。

仿製药市场 - 地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。越来越多的政府优惠倡议，加上产品上市数量和仿製药需求的不断增加，是北美地区的主要收入驱动力。

仿製药市场-竞争格局：

  • 由于未来几年空调需求的持续发展，全球空气对空气热泵市场由国际和本地生产商组成，使其成为世界上最具竞争力的行业之一。公司通过多种渠道销售产品，包括企业网站、电子商务网站、零售商、分销商和最终消费者。产品製造商在多个方面进行竞争，包括产品成本、性能、产品製造、分销、声誉和可用性。
  • 企业用来扩大影响力和扩大市场份额的一些主要技术包括新产品发布、产品网络开发、研发支出以及併购。例如，2022 年 11 月，美国卫生当局允许 Glenmark Pharmaceuticals 在美国销售苯丁酸钠片剂，这是一种用于治疗尿素循环障碍的药物。

最近的发展：

2022 年 10 月，Glenmark 的美国分部将用于治疗多发性硬化症的仿製药芬戈莫德胶囊引入美国市场。

该研究的主要特点：

  • 这项拟议的仿製药市场研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年
  • 该报告为客户提供有关仿製药市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了仿製药市场有吸引力的投资主张矩阵
  • 总体报告确定了新的投资机会、老牌企业面临的挑战以及维持仿製药市场的增长因素
  • COVID-19 对仿製药市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将涵盖对新冠疫情后仿製药市场的详细见解。
  • 为了让本报告的用户全面了解仿製药市场，我们还包括仿製药市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这将帮助用户了解在仿製药市场运营的参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球仿製药市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师

目录

第一章：仿製药市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的仿製药市场片段
    • 按给药途径分類的仿製药市场片段
    • 按产品分类的仿製药市场片段
    • 按应用分類的仿製药市场片段
    • 按国家/地区分類的仿製药市场摘要
    • 按地区分類的仿製药市场片段
  • 竞争洞察

第 3 章：仿製药主要市场趋势

  • 仿製药市场驱动因素
    • 市场驱动因素的影响分析
  • 仿製药市场限制
    • 市场限制影响分析
  • 仿製药市场机会
  • 仿製药市场未来趋势

第 4 章：仿製药行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：仿製药市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：仿製药市场格局

  • 2022 年仿製药市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：仿製药市场 - 按类型

  • 概述
    • 按类型分類的细分市场份额分析
    • 简单泛型
    • 专业仿製药
    • 生物仿製药

第 8 章：仿製药市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 口服
    • 可注射
    • 吸入式
    • 其他的

第 9 章：仿製药市场 - 副产品

  • 概述
    • 按产品分類的细分市场份额分析
    • 小分子
    • 大分子

第 10 章：仿製药市场 -按应用

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 中枢神经系统疾病
    • 呼吸疾病
    • 激素及相关疾病
    • 胃肠道疾病
    • 心血管疾病
    • 传染性疾病
    • 癌症
    • 糖尿病
    • 其他的

第 11 章：仿製药市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 北美仿製药主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按管理途径）
    • 北美市场规模和预测（按产品）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲仿製药主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按类型）
    • 欧洲市场规模和预测（按管理途径）
    • 欧洲市场规模和预测（按产品）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区仿製药主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按类型）
    • 亚太地区市场规模和预测（按管理途径）
    • 亚太地区市场规模和预测（按产品）
    • 亚太地区市场规模和预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲仿製药主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按类型）
    • 拉丁美洲市场规模和预测（按管理途径）
    • 拉丁美洲市场规模和预测（按产品）
    • 拉丁美洲市场规模和预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲非专利药品主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按应用）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 仿製药行业

  • 竞争仪表板
  • 公司简介
    • Zydus Cadila
    • Torrent Pharmaceuticals
    • Teva Pharmaceutical Industries
    • Sun Pharmaceutical Industries
    • Sandoz (a subsidiary of Novartis)
    • Mylan (now part of Viatris)
    • Lupin Pharmaceuticals
    • Hikma Pharmaceuticals
    • Glenmark Pharmaceuticals
    • Fresenius Kabi
    • Endo International (through its subsidiary Par Pharmaceutical)
    • Dr. Reddy's Laboratories
    • Cipla
    • Aurobindo Pharma
    • Apotex

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1628

REPORT HIGHLIGHT

Generic Pharmaceuticals Market size was valued at USD 361,701.0 Million in 2022, expanding at a CAGR of 8.31% from 2023 to 2030.

Generic medicines are non-branded drugs with the same active components, dosage form, potency, and intended purpose as brand-name drugs. Following the termination of the patent protection for the original medicine, these products are created and marketed. To assure their safety, quality, and efficacy, generic medications must pass stringent regulatory clearance procedures. Generic medicines are often less expensive than name-brand medications since there are no expenditures associated with research and development. While preserving similar therapeutic efficacy to their branded versions, they help extend access to vital pharmaceuticals and are crucial in lowering healthcare costs.

Generic Pharmaceuticals Market- Market Dynamics:

  • Increasing incidence of chronic diseases.
  • The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more people are given a chronic disease diagnosis, they seek out additional medications to treat it. Branded medications cost more, whereas generic medications cost less and share the same chemical make-up as branded medications. Patients choose generic medications over branded medications due to the lower cost, consistency in chemical makeup, and potency of generic medications. As a result of the extended duration of therapy for chronic diseases, generic medicine sales also rise. For instance, the WHO (World Health Organization) predicts a 17% rise in the number of chronic disease-related fatalities during the next ten years.

Generic Pharmaceuticals Market- Key Insights:

  • As per the analysis shared by our research analyst, the global generic pharmaceutical market is estimated to grow annually at a CAGR of around 8.31% over the forecast period (2023-2030)
  • Based on type segmentation, simple generic products were predicted to show maximum market share in the year 2022
  • Based on application, cardiovascular was the leading type in 2022
  • Based on product segmentation, the small molecule was the leading type in 2022
  • Based on route of administration segmentation, oral was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Generic Pharmaceuticals Market- Segmentation Analysis:

  • The Global Generic Pharmaceuticals Market is segmented based on Type, Route of Administration, Product, Application, and Region.
  • The market is divided into categories based on Type: Simple Generics, Specialty Generics, and Biosimilars. The Simple Generics sector dominates the market. The simple generic products need to conduct bioequivalence studies and have a defined development plan and regulatory approach. These items are chemically identical to their reference counterparts, and the market is already overflowing with straightforward generic products. Nevertheless, the market is anticipated to expand as a result of government attempts to cut healthcare spending on medicines and increase new approvals and launches.
  • The market is divided into categories based on Route of Administration: Oral, Injectable, Inhalable, and Others. The oral segment dominates the market. The many benefits of oral dose, including its simplicity and lack of nursing needs, increase patient acceptance and compliance. For the treatment of COVID-19 patients, Zenera Pharma introduced a generic version of Paxlovid in September 2022. Each box of these oral medications, which contains 20 Nirmatrelvir pills, costs USD 63.74.

Generic Pharmaceuticals Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. An increasing number of favorable government initiatives coupled with the rising number of product launches and demand for generic drugs is a key revenue driver in North American region.

Generic Pharmaceuticals Market- Competitive Landscape:

  • Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution, reputation, and availability.
  • Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, Product network development, R&D spending, and mergers and acquisitions. For instance, in November 2022, The US health authority gave Glenmark Pharmaceuticals permission to sell sodium phenylbutyrate tablets, a medication used to treat urea cycle disorders, in the US.

Recent Developments:

In October 2022, Generic Fingolimod capsules, utilized for the treatment of multiple sclerosis, were introduced to the American market by Glenmark's American-based division.

Key features of the study:

  • This proposed research study on Generic Pharmaceuticals market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Generic Pharmaceuticals market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Generic Pharmaceuticals market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Generic Pharmaceuticals market
  • Impact of COVID-19 on Generic Pharmaceuticals market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Generic Pharmaceuticals market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Generic Pharmaceuticals market, we have also included competitive landscape and key innovator analysis for the Generic Pharmaceuticals market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Generic Pharmaceuticals market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Generic Pharmaceuticals market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC PHARMACEUTICALS MARKET KEY PLAYERS

  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Sandoz (a subsidiary of Novartis)
  • Mylan (now part of Viatris)
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Fresenius Kabi
  • Endo International (through its subsidiary Par Pharmaceutical)
  • Dr. Reddy's Laboratories
  • Cipla
  • Aurobindo Pharma
  • Apotex

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE

  • Simple Generics
  • Specialty Generics
  • Biosimilars

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Injectable
  • Inhalable
  • Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT

  • Small Molecule
  • Large Molecule

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION

  • Central Nervous System Disorders
  • Respiratory Diseases
  • Hormones & Related Diseases
  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Cancer
  • Diabetes
  • Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Generic Pharmaceuticals Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Generic Pharmaceuticals Market Snippet by Type
    • 2.1.2. Generic Pharmaceuticals Market Snippet by Route of Administration
    • 2.1.3. Generic Pharmaceuticals Market Snippet by Product
    • 2.1.4. Generic Pharmaceuticals Market Snippet by Application
    • 2.1.5. Generic Pharmaceuticals Market Snippet by Country
    • 2.1.6. Generic Pharmaceuticals Market Snippet by Region
  • 2.2. Competitive Insights

3. Generic Pharmaceuticals Key Market Trends

  • 3.1. Generic Pharmaceuticals Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Generic Pharmaceuticals Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Generic Pharmaceuticals Market Opportunities
  • 3.4. Generic Pharmaceuticals Market Future Trends

4. Generic Pharmaceuticals Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Generic Pharmaceuticals Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Generic Pharmaceuticals Market Landscape

  • 6.1. Generic Pharmaceuticals Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Generic Pharmaceuticals Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Simple Generics
    • 7.1.3. Specialty Generics
    • 7.1.4. Biosimilars

8. Generic Pharmaceuticals Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable
    • 8.1.4. Inhalable
    • 8.1.5. Others

9. Generic Pharmaceuticals Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 9.1.2. Small Molecule
    • 9.1.3. Large Molecule

10. Generic Pharmaceuticals Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 10.1.2. Central Nervous System Disorders
    • 10.1.3. Respiratory Diseases
    • 10.1.4. Hormones & Related Diseases
    • 10.1.5. Gastrointestinal Diseases
    • 10.1.6. Cardiovascular Diseases
    • 10.1.7. Infectious Diseases
    • 10.1.8. Cancer
    • 10.1.9. Diabetes
    • 10.1.10. Others

11. Generic Pharmaceuticals Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Generic Pharmaceuticals Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Generic Pharmaceuticals Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Generic Pharmaceuticals Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Generic Pharmaceuticals Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Generic Pharmaceuticals Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Generic Pharmaceuticals Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Zydus Cadila
    • 12.2.2. Torrent Pharmaceuticals
    • 12.2.3. Teva Pharmaceutical Industries
    • 12.2.4. Sun Pharmaceutical Industries
    • 12.2.5. Sandoz (a subsidiary of Novartis)
    • 12.2.6. Mylan (now part of Viatris)
    • 12.2.7. Lupin Pharmaceuticals
    • 12.2.8. Hikma Pharmaceuticals
    • 12.2.9. Glenmark Pharmaceuticals
    • 12.2.10. Fresenius Kabi
    • 12.2.11. Endo International (through its subsidiary Par Pharmaceutical)
    • 12.2.12. Dr. Reddy's Laboratories
    • 12.2.13. Cipla
    • 12.2.14. Aurobindo Pharma
    • 12.2.15. Apotex

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Generic Pharmaceuticals Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Generic Pharmaceuticals Market, by Type 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Generic Pharmaceuticals Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Generic Pharmaceuticals Market, by Product 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Generic Pharmaceuticals Market, by Application 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Generic Pharmaceuticals Market, by Region 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Generic Pharmaceuticals Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Europe Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Asia Pacific Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Latin America Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Germany Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE India Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Brazil Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Saudi Arabia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)